Post-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United Kingdom

NCT00996853 · clinicaltrials.gov ↗

COMPLETED

Status

9206

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

OTHER: Safety follow up

Sponsor

GlaxoSmithKline